Do smoking intensity-related differences in vigilance indicate altered glucocorticoid receptor sensitivity?

Addiction Biology

Volumn 9, Issue 1, 2004, Pages 35-41

  Reuter, Martin ^a   Hennig, Juergen ^a   Netter, Petra ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; METYRAPONE;

ADULT; ALERTNESS; ARTICLE; CONTROLLED STUDY; CRITICAL FLICKER FUSION; HUMAN; HYDROCORTISONE RELEASE; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RECEPTOR SENSITIVITY; SMOKING; SMOKING CESSATION;

ADULT; AROUSAL; DEXAMETHASONE; ENZYME INHIBITORS; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; INCIDENCE; MALE; METYRAPONE; RECEPTORS, GLUCOCORTICOID; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SMOKING;

EID: 2342561750     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1080/13556210410001674077     Document Type: Article

References (34)

1. Piazza PV, LeMoal M. Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annu Rev Pharmacol Toxicol 1996;36: 359-78.
2. Goeders NE, Wagner LA, Marshall SB, Guerin G. Effects of metyrapone on intravenous cocaine self-administration in rats. Soc Neurosci Abstr 1993;19:760.11.
3. Reuter M, Netter P, Rogausch A, Sander P, Kaltschmidt M, Dōrr A, Hennig J. The role of cortisol suppression on craving for and satisfaction from nicotine in high and low impulsive subjects. Hum Psychopharmacol Clin Exp 2002;17:213-24.
4. Piazza PV, Maccari S, Demeniere JM, LeMoal M, Mormede P, Simon H. Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc Natl Acad Sci USA 1991; 88:2088-92.
5. Rougé-Pont F, Marinelli M, LeMoal M, Simon H, Piazza, FV. Stress induced sensitization and glucocorticoids. II. Sensitization of the increase in extracellular dopamine induced by cocaine depends on stress induced corticosterone secretion. J Neurosci 1995;15:7189-95.
6. Goeders NE, Guerin GF. Effects of surgical and pharmacological adrenalectomy on the initiation and maintenance of intravenous cocaine self-administration in rats. Brain Res 1996;722:145-52.
7. Imperato A, Puglisi-Allegra S, Casolini P, Zocchi A, Angelucci L. Stress-induced enhancement of dopamine and acetylcholine release in limbic structures: role of corticosterone. Eur J Pharmacol 1989;165:337-8.
8. Härfstrand A, Fuxe K, Cintra A, et al. Glucocorticoid receptor immunoreactivity in monoaminergic neurons of rat brain. Proc Natl Acad Sci USA 1986;83:9779-83.
9. Spanagel R, Weiss F. The dopamine hypothesis of reward: past and current status. Trends Neurosci 1999;22:521-7.
10. Sala M, Braida D, Colombo M, et al. Behavioral and biochemical evidence of opioidergic involvement in cocaine sensitization. J Pharmacol Exp Ther 1995;274:450-7.
11. Rossetti ZL, Hmaidan Y, Gessa GL. Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur J Pharmacol 1992;221:227-34.
12. Stalke J, Hader O, Hensen J, Bähr V, Scherer G, Oelkers W. Nicotine infusion in man stimulates plagma-vasopressin, -ACTH and -cortisol in a dose dependent manner. In: Adlkofer F, Thurau K, editors. Effects of nicotine on biological systems. Basel: Birkhäuser, 1991; pp. 339-43.
13. Koob GF, LeMoal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001;24:97-129.
14. Born J, Zwick A, Roth G, Fehm-Wolfsdorf G, Fehm HL. Differential effects of hydrocortisone, fluocortolone, and aldosterone on nocturnal sleep in humans. Acta Endocrinol 1987;116:129-37.
15. Born J, De Kloet ER, Wenz H, Fehm HL. Gluco-and antimineralocorticoid effects on human sleep: a role of central corticosteroid receptors. Am J Physiol 1991;260:183-8.
16. Croiset G, Nijsen MJ, Kamphuis PJ. Role of corticotropin-releasing factor, vasopressin and the autonomic nervous system in learning and memory. Eur J Pharmacol 2000;405:225-34.
17. Born J, Hitzler V, Pietrowsky R, Pauschinger P, Fehm HL. Influences of cortisol on auditory evoked potentials (AEPs) and mood in humans. Neuropsychobiology 1988;20:145-51.
18. Woodbury DM. Biochemical effects of adrenocortical steroids on the central nervous system. In: Lajtha A, editor. Handbook of neurochemistry. New York: Plenum, 1972, pp. 255-87.
19. Feldman S, Todt JC, Porter RW. Effect of adrenocortical hormones on the electrical activity of the brain. Neurology 1961;11:109-15.
20. Phillips MI, Dafny N. Effects of cortisol on unit activity in freely-moving rats. Brain Res 1971;25: 651-5.
21. Steiner FA, Ruf K, Akert K. Steroid-sensitive neurons in rat brain: anatomical localization and responses to neurohumors and ACTH. Brain Res 1969;12:74-85.
22. Beaumont K, Fanestil DD. Characterization of rat brain aldosterone receptors reveals high affinity for corticosterone. Endocrinology 1983;113:2043-51.
23. Reul JMHM, De Kloet ER. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 1985; 117:2505-11.
24. Reuter M. Cortisol and emotion: an experimental pharmacopsychological approach. Hamburg: Kovac, 2001.
25. Fehm HJ, Born J. Non-traditional aspects in the control of cortisol secretion. In: Weiner H, Florin I, Murison R, Hellhanimer D, editors. Frontiers of stress research. Toronto: Huber, 1989; pp. 251-61.
26. Ness-Abramof R, Nabriski D, Apovian CM, et al. Overnight dexamethasone suppression test: a reliable screen for Cushing's syndrome in the obese. Obes Res 2002;10:1217-21.
27. Lupien SJ, Wilkinson CW, Briere S, Menard C, Ng Yin Kin NM, Nair NP. The modulatory effects of corticosteroids on cognition: studies in young human populations. Psychoneuroendocrinology 2002;27:401-16.
28. Wilkinson CW, Petrie EC, Murray SR, Colasurdo EA, Raskind MA, Peskind ER. Human ghicocorticoid feedback inhibition is reduced in older individuals: evening study. J Clin Endocrinol Metab, 2001;86:545-50.
29. Heatherton TF, Kozlowski LT, Kecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 1991;86:1119-27.
30. Janke W, Debus G. Die Eigenschaftswörterliste (EWL). Göttingen: Hogrefe.
31. Fisher RA. The design of experiments. Edinburgh: Oliver & Boyd, 1935.
32. Reuter M, Netter P, Toll C, Hennig J. Dopamine agonist and antagonist responders as related to types of nicotine craving and facets of extroversion. Prog Neuro-Psychopharmacol Biol Psychiatry 2002;26:845-53.
33. Griffiths RR, Troisi JR, Silverman K, Mumford GK. Multiple-choice procedure: an efficient approach for investigating drug reinforcement in humans. Behav Pharmacol 1993;4:3-13.
34. Mantsch JR, Saphier D, Goeders NE. Corticosterone facilitates the acquisition of cocaine self-administration in rats: opposite effects of the type II glucocorticoid receptor agonist dexamethasone. J Pharmacol Exp Ther 1998;287:72-80.